- World rank, all time
- #41,190 of 42,892
- Rank in United States
- #8,515 of 8,685
- Research works
- 128 ▲ 79% vs 2013–17
- Citations
- 1.2k 9.0 per fractional work
- Top-10% rate
- 5.5% record average 16.5%
- Open access
- 38% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Economics, Econometrics and Finance 3.6×
- Biochemistry, Genetics and Molecular Biology 1.3×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Environmental Science 0.6×
- Health Professions 0.6×
- Agricultural and Biological Sciences 0.5×
- Immunology and Microbiology 0.4×
- Neuroscience 0.3×
- Decision Sciences 0.2×
- Mathematics 0.1×
- Chemistry 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.0×
Who are the top researchers at Ipsen (United States)?
Ranked on the composite score, Floris A. de Jong, Paul Cockrum and Beloo Mirakhur lead among researchers whose main affiliation is Ipsen (United States).
- 1 Floris A. de Jong United States · #1,351,230 worldwide 36 citations · 15 works
- 2 Paul Cockrum United States · #1,400,606 worldwide 13 citations · 16 works
- 3 Beloo Mirakhur United States · #1,587,978 worldwide 9 citations · 20 works
Which keywords describe research at Ipsen (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Targeted Therapy, Clinical Trials, Prognostic Factors, Biomarkers, Genomic Profiles and Small-Cell Lung Cancer.
- Perchlorate
- Pancreatic Neuroendocrine Tumors
- Liver Transplantation
- Financial Toxicity
- Heterotopic Ossification
- Prevention
- Neurotoxins
- Quality of Life
- Pain Management
- Neurological Disorders
- Surgical Complications
- Tumor Microenvironment
- Small-Cell Lung Cancer
- Biomarkers
- Clinical Trials
- Immunotherapy
- Chemotherapy
- Targeted Therapy
- Prognostic Factors
- Genomic Profiles
- Epidemiology
- Pancreatic Cancer
- Treatment
- Genetic Mutations
- Stroke
- Botulinum Toxin
- Pathophysiology
- Fibrodysplasia Ossificans Progressiva
- Cost of Care
- Immunosuppressive Therapy
- Neuroendocrine Tumors
- Management
- Thyroid
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 33 words, with their numbers
- Chemotherapy6▲ 29×8 topics
- Immunotherapy6▲ 28×8 topics
- Targeted Therapy4▲ 61×3 topics
- Clinical Trials4▲ 20×5 topics
- Prognostic Factors4▲ 26×6 topics
- Biomarkers3▲ 14×2 topics
- Genomic Profiles3▲ 232×1 topic
- Small-Cell Lung Cancer3▲ 232×1 topic
- Epidemiology3▲ 2.2×11 topics
- Tumor Microenvironment3▲ 20×3 topics
- Pancreatic Cancer2▲ 69×1 topic
- Surgical Complications2▲ 94×1 topic
- Treatment2▲ 5.5×4 topics
- Neurological Disorders2▲ 10×4 topics
- Genetic Mutations2▲ 13×5 topics
- Pain Management2▲ 25×4 topics
- Stroke2▲ 30×2 topics
- Quality of Life2▲ 3.4×5 topics
- Botulinum Toxin2▲ 78×1 topic
- Neurotoxins2▲ 125×1 topic
- Pathophysiology1▲ 14×2 topics
- Prevention1▲ 9.7×2 topics
- Fibrodysplasia Ossificans Progressiva1▲ 671×1 topic
- Heterotopic Ossification1▲ 671×1 topic
- Cost of Care1▲ 120×1 topic
- Financial Toxicity1▲ 120×1 topic
- Immunosuppressive Therapy1▲ 19×2 topics
- Liver Transplantation1▲ 30×3 topics
- Neuroendocrine Tumors1▲ 107×1 topic
- Pancreatic Neuroendocrine Tumors1▲ 107×1 topic
- Management1▲ 4.2×3 topics
- Perchlorate1▲ 757×1 topic
- Thyroid1▲ 757×1 topic
Which research topics does Ipsen (United States) publish most on?
By volume in 2022–2025: Lung Cancer Research Studies, Pancreatic and Hepatic Oncology Research, Botulinum Toxin and Related Neurological Disorders and Heterotopic Ossification and Related Conditions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Research Studies Oncology 3 works
- 2 Pancreatic and Hepatic Oncology Research Oncology 2 works
- 3 Botulinum Toxin and Related Neurological Disorders Neurology 2 works
- 4 Heterotopic Ossification and Related Conditions Rheumatology 1 works
- 5 Neuroendocrine Tumor Research Advances Epidemiology 1 works
- 6 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 7 Chemical Analysis and Environmental Impact Health, Toxicology and Mutagenesis 1 works
- 8 Stroke Rehabilitation and Recovery Rehabilitation 1 works
- 9 Liver Diseases and Immunity Hepatology 1 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ipsen (United States)'s research output changed?
Output in 2018–2022 was 79% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.